Polymorphisms of Superoxide Dismutase, Glutathione Peroxidase and Catalase Genes in Patients with Post-transplant Diabetes Mellitus

Archives of Medical Research

Volumn 41, Issue 5, 2010, Pages 350-355

  Dutkiewicz, Grazyna ^a   Domanski, Leszek ^a   Pawlik, Andrzej ^a   Binczak Kuleta, Agnieszka ^a   Safranow, Krzysztof ^a   Ciechanowicz, Andrzej ^a   Dziedziejko, Violetta ^a   Pietrzak Nowacka, Maria ^a   Ciechanowski, Kazimierz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Graft; Kidney; Post transplant diabetes mellitus; Tacrolimus

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTTRANSPLANT DIABETES MELLITUS;

BASE SEQUENCE; CATALASE; DIABETES MELLITUS; DNA PRIMERS; GLUTATHIONE PEROXIDASE; HUMANS; POLYMORPHISM, GENETIC; SUPEROXIDE DISMUTASE; TRANSPLANTATION;

EID: 77956852217     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.06.006     Document Type: Article

References (31)

1. Weir M.R., Fink J.C. Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999, 34:1-13.
2. Gomes M.B., Cobas R.A. Post-transplant diabetes mellitus. Diabetol Metab Syndr 2009, 1:14.
3. Friederich M., Hansell P., Palm F. Diabetes, oxidative stress, nitric oxide and mitochondria function. Curr Diabetes Rev 2009, 5:120-144.
4. Tilney N.L., Paz D., Ames M., et al. Ischemia-reperfusion injury. Transpl Proc 2001, 33:843-844.
5. Chien C.T., Lee P.H., Chen C.F., et al. De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol 2001, 12:973-982.
6. Arduini A., Mezzetti A., Porreca E., et al. Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. Biochim Biophys Acta 1988, 970:113-121.
7. Kurokawa T., Kobayashi H., Nonami T., et al. Mitochondrial glutathione redox and energy producing function during liver ischemia and reperfusion. J Surg Res 1996, 66:1-5.
8. Shiraishi T., Kuroiwa A., Shirakusa T., et al. Free radical-mediated tissue injury in acute lung allograft rejection and the effect of superoxide dismutase. Ann Thorac Surg 1997, 64:821-825.
9. Flekac M., Skrha J., Hilgertova J., et al. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med Genet 2008, 9:30.
10. Mak J.C., Ho S.P., Yu W.C., et al. Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD. Eur Respir J 2007, 30:684-690.
11. Choi J.Y., Neuhouser M.L., Barnett M., et al. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev 2007, 16:1115-1120.
12. Puavilai G., Chanprasertyotin S., Sriphrapradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Res Clin Pract 1999, 44:21-26.
13. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003;75:3-24.
14. Ukkola O., Erkkilä P.H., Savolainen M.J., et al. Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med 2001, 249:451-459.
15. Goulas A., Fidani L., Kotsis A., et al. An association study of a functional catalase gene polymorphism, -262C->T, and patients with Alzheimer's disease. Neurosci Lett 2002, 330:210-213.
16. Sato T., Inagaki A., Uchida K., et al. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation 2003, 76:1320-1326.
17. Mollar-Puchades M.A., Malek-Marin T., Merino-Torres J.F., et al. Diabetes mellitus after kidney transplantation: role of the impaired fasting glucose in the outcome of kidney transplantation. J Endocrinol Invest 2009, 32:263-266.
18. Kamar N., Mariat C., Delahousse M., et al. Diabetes mellitus after kidney transplantation: a French multicentre observational study. Nephrol Dial Transplant 2007, 22:1986-1993.
19. Vincenti F., Friman S., Scheuermann E., et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007, 7:1506-1514.
20. Pirsch J.D., Miller J., Deierhoi M.H., et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997, 63:977-983.
21. Krämer B.K., Del Castillo D., Margreiter R., et al. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results. Nephrol Dial Transpl 2008, 23:2386-2392.
22. Whiting P.H., Kalansooriya A., Holbrook I., et al. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci 2008, 65:71-74.
23. Murakami K., Kondo T., Ohtsuka Y., et al. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 1989, 38:753-758.
24. Sharma A., Kharb S., Chugh S.N., et al. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism 2000, 49:160-162.
25. Yoshida K., Hirokawa J., Tagami S., et al. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 1995, 38:201-210.
26. Likidlilid A., Patchanans N., Poldee S., et al. Glutathione and glutathione peroxidase in type 1 diabetic patients. J Med Assoc Thai 2007, 90:1759-1767.
27. Mysore T.B., Shinkel T.A., Collins J., et al. Overexpression of glutathione peroxidase with two isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function. Diabetes 2005, 54:2109-2116.
28. Takeshita S., Inoue N., Ueyama T., et al. Shear stress enhances glutathione peroxidase expression in endothelial cells. Biochem Biophys Res Commun 2000, 273:66-71.
29. Forgione M.A., Weiss N., Heydrick S., et al. Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol 2002, 282:1255-1261.
30. Hamanishi T., Furuta H., Kato H., et al. Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients. Diabetes 2004, 53:2455-2460.
31. Nemoto M., Nishimura R., Sasaki T., et al. Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography. Cardiovasc Diabetol 2007, 6:23.